Pages that link to "Q84268233"
Jump to navigation
Jump to search
The following pages link to Low dose pioglitazone does not affect bone formation and resorption markers or bone mineral density in streptozocin-induced diabetic rats (Q84268233):
Displaying 7 items.
- Cilostazol renoprotective effect: modulation of PPAR-γ, NGAL, KIM-1 and IL-18 underlies its novel effect in a model of ischemia-reperfusion (Q28538659) (← links)
- Effects of vitamin D combined with pioglitazone hydrochloride on bone mineral density and bone metabolism in Type 2 diabetic nephropathy (Q33792658) (← links)
- Alleviating effects of morin against experimentally-induced diabetic osteopenia (Q36639407) (← links)
- Changes in bone biological markers after treatment of Iranian diabetic patients with pioglitazone: No relation to polymorphism of PPAR-γ (Pro12Ala). (Q37222124) (← links)
- Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review (Q38441017) (← links)
- Pulsed electromagnetic fields inhibit bone loss in streptozotocin-induced diabetic rats (Q85661114) (← links)
- Diabetes pharmacotherapy and effects on the musculoskeletal system (Q93364919) (← links)